Stock Events

Stock Events

Nexien BioPharma 

$0.000100
5
+$0.00+0%Wednesday 20:00

Statistics

Day High
0.0018
Day Low
0.0018
52W High
0.012
52W Low
0.0001
Volume
115,000
Avg. Volume
596
Mkt Cap
7,077.2
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Nov 9Expected
Q4 2020
Q1 2021
Q1 2021
Q3 2021
Q4 2021
Q1 2022
Q3 2022
-0.01
-0.01
-0
0
Expected EPS
0
Actual EPS
-0.0016

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-188,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap81.62M
Corbus Pharmaceuticals works on developing and commercializing novel therapeutics to treat inflammatory and fibrotic diseases, overlapping with Nexien's therapeutic areas.
Aurora Cannabis
ACB
Mkt Cap257.04M
Aurora Cannabis is a major player in the cannabis industry, indirectly competing with Nexien by developing cannabis-based medical treatments.
Tilray Brands
TLRY
Mkt Cap373.9M
Tilray is a global leader in cannabis research, cultivation, processing, and distribution, potentially competing in the medical cannabis market space with Nexien.
Canopy Growth
CGC
Mkt Cap276.03M
Canopy Growth Corporation is a world-leading diversified cannabis and cannabinoid-based medicines company, competing in the same industry as Nexien.
Curaleaf
CURLF
Mkt Cap2.5B
Curaleaf Holdings is a leading U.S. provider of consumer products in cannabis, with a broad spectrum of products that could compete with Nexien's cannabinoid-based therapeutics.

About

Nexien BioPharma, Inc., a pharmaceutical firm headquartered in Glendale, Colorado, concentrates its efforts on the research, advancement, and market introduction of cannabinoid-derived medications. The company utilizes both pre-clinical and clinical development paths to address a variety of diseases, medical conditions, and disorders. It adopted its current name in September 2018, having previously operated as Intiva BioPharma Inc.
Show More
CEO
Richard S. Greenberg
Employees
10
Country
United States
ISIN
US65343D1000

Listings

OTC Link
US
NXEN

0 Comments

Share your thoughts

FAQs

What is Nexien BioPharma stock price today?▼
The current price of NXEN is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Nexien BioPharma stock price performance more closely on the chart.
What is Nexien BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Nexien BioPharma stocks are traded under the ticker NXEN.
Is Nexien BioPharma stock price growing?▼
NXEN stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Nexien BioPharma has showed a -99.17% decrease.
What is Nexien BioPharma market cap?▼
Today Nexien BioPharma has the market capitalization of 7,077.2
What were Nexien BioPharma earnings last quarter?▼
NXEN earnings for the last quarter are -0 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nexien BioPharma revenue for the last year?▼
Nexien BioPharma revenue for the last year amounts to 0 USD.
What is Nexien BioPharma net income for the last year?▼
NXEN net income for the last year is -188,000 USD.
How many employees does Nexien BioPharma have?▼
As of November 2, 2026, the company has 10 employees.
In which sector is Nexien BioPharma located?▼
Nexien BioPharma operates in the Health & Wellness sector.
When did Nexien BioPharma complete a stock split?▼
The last stock split for Nexien BioPharma was on November 29, 2017 with a ratio of 1:6.
Where is Nexien BioPharma headquartered?▼
Nexien BioPharma is headquartered in Glendale, United States.